Persistence and compliance with medication management in the treatment of overactive bladder
Authors:
Open Access
- 1 January 2016
- journal article
- review article
- Published by The Korean Urological Association in Investigative and Clinical Urology
- Vol. 57 (2) , 84-93
Abstract
Kim TH, et al. Investig Clin Urol. 2016 Mar;57(2):84-93. http://dx.doi.org/10.4111/icu.2016.57.2.84Keywords
This publication has 62 references indexed in Scilit:
- Effect of Urgency Symptoms on the Risk of Depression in Community-Dwelling Elderly MenKorean Journal of Urology, 2013
- Persistence with prescribed antimuscarinic therapy for overactive bladder: a UK experienceBJU International, 2012
- Patient‐reported reasons for discontinuing overactive bladder medicationBJU International, 2010
- Practical aspects of lifestyle modifications and behavioural interventions in the treatment of overactive bladder and urgency urinary incontinenceInternational Journal Of Clinical Practice, 2009
- Long‐term safety, tolerability, and efficacy of the novel anti‐muscarinic agent imidafenacin in Japanese patients with overactive bladderInternational Journal of Urology, 2008
- The Effects of Antimuscarinic Treatments in Overactive Bladder: An Update of a Systematic Review and Meta-AnalysisEuropean Urology, 2008
- Medication Compliance and Persistence: Terminology and DefinitionsValue in Health, 2008
- Is the Prevalence of Overactive Bladder Overestimated? A Population-Based Study in FinlandPLOS ONE, 2007
- Randomized, double‐blind placebo‐ and tolterodine‐controlled trial of the once‐daily antimuscarinic agent solifenacin in patients with symptomatic overactive bladderBJU International, 2004
- Twelve-Month Treatment of Overactive BladderDrugs & Aging, 2001